Squamous Cell Carcinoma of Esophagus Not Yet Recruiting Phase 2 Trials for Camrelizumab (DB14776)

Also known as: Esophageal Squamous Cell Carcinoma (ESCC) / Esophageal Squamous Cell Carcinoma / Esophageal Squamous Cell Carcinomas / Oesophageal squamous cell carcinoma / Esophageal squamous cell carcinoma stage unspecified / Oesophageal epidermoid carcinoma NOS / Esophageal epidermoid carcinoma NOS / Squamous cell carcinoma of oesophagus / Squamous cell carcinoma of esophagus NOS / Oesophageal squamous cell carcinoma NOS / Oesophageal squamous cell carcinoma stage unspecified

IndicationStatusPhase
DBCOND0031573 (Squamous Cell Carcinoma of Esophagus)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03817658A Phase II Study of SHR-1210 vs Placebo as Consolidation Chemotherapy After Radical Concurrent Chemoradiotherapy in Locally Advanced ESCCTreatment
NCT03766178Study of Anti-PD-1 Antibody SHR-1210 Plus Nimotuzumab in the Treatment of Advanced Esophageal Squamous Cell CarcinomaTreatment